跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 438 条关于
“BRCAm”
全部
438
临床试验
399
药物
4
机构
0
资讯
35
2年前
Immunotherapy Shows Promise in Prostate Cancer with MMRd Mutation
去年
Global Survey Reveals Critical Knowledge Gaps in Genetic Testing for Ovarian Cancer Treatment
去年
Niraparib Shows Promise in Extending Progression-Free Survival in Epithelial Ovarian Cancer
8个月前
858 Therapeutics Receives FDA Fast Track Designation for PARG Inhibitor ETX-19477 in BRCA-Mutated Ovarian Cancer
去年
Niraparib and Dostarlimab Show Promise in BRCA-Mutated, ER+/HER2- Breast Cancer
去年
BRCA2 Mechanism Reveals Why PARP Inhibitors Work in Only Some Cancer Patients
去年
Olaparib Provides Long-Term Survival Benefit in BRCA2-Mutated Ovarian Cancer
2年前
FDA Approves FoundationOne CDx and Liquid CDx as Companion Diagnostics for Olaparib Plus Abiraterone in BRCA-Mutated mCRPC
去年
FDA Approves J&J's Akeega for BRCA-Positive Metastatic Prostate Cancer
去年
Blood Test Detects PARPi Resistance in Ovarian Cancer Patients with BRCA1 Mutations
第 1 页,共 4 页
上一页
下一页